AURA Paris

What AURA Paris does

AURA Paris is a French non-profit healthcare organization founded in 1967 by Prof Hamburger and operating as an ESPIC (Établissement de Santé Privé d'Intérêt Collectif), currently transitioning to a Fondation Reconnue d'Utilité Publique (FRUP). It is the first dialysis association in Île-de-France and operates the region's largest dialysis network, with 14 centers serving approximately 2,500 active patients — roughly a quarter of the Greater Paris dialysis population — across in-center hemodialysis (including a 60-station facility at Plaisance), peritoneal and home hemodialysis (440 patients), a 24-bed hospitalization unit, day hospital, and consultations. The organization employs 101–250 staff and generates revenue under French T2A reimbursement tariffs, with published unit prices including €1,139.70/day for medicine, €302/day for SMR, €905.16 for day hospital, and €23 per consultation.

The organization's core activity is the integrated medical management of chronic kidney disease from pre-dialysis (CKD) through end-stage renal disease, including autonomous and home modalities. AURA distinguishes itself through academic engagement: it participates in major nephrology research cohorts (CKD-REIN, REIN, RDPLF, DOPPS), runs the FID training center, co-created a Diplôme d'Université with Université Paris-Saclay, and counts two members of the Académie de médecine on its staff (including Prof Ziad Massy, elected 2024). It achieved HAS certification with a 99% score on the patient chapter in 2024.

The business model is reimbursement-driven under the French national health insurance system: AURA bills the Assurance Maladie for clinical acts and dialysis sessions at regulated T2A tariffs, with no direct enterprise customers and a B2C model mediated by Sécurité sociale. Recent strategic activity includes the inauguration of a new Châtillon center (2024) with 16 UDM and 6 UAD stations, ongoing discussions with CHSF for additional units and a day hospital, active international collaborations across Africa, Southeast Asia, the Middle East, and Saudi Arabia, and clinical leadership expansion through multiple new physician appointments.

Name

AURA Paris

Legal name

AURA (Association pour l'Utilisation du Rein Artificiel)

Website

https://auraparis.org

Company type

Private

Founded year

1967

Operating status

Operating

Headcount range

101–250 employees

Short description

AURA Paris is a French non-profit ESPIC founded in 1967 operating the largest dialysis network in Île-de-France, with 14 centers serving 2,500 chronic kidney disease and end-stage renal disease patients via in-center, home, and autonomous dialysis modalities reimbursed through the French national health insurance system.

Ownership category

akta.pro rank

Product category

Dialysis & Nephrology Services

NAICS

Kidney Dialysis Centers (621492), Ambulatory Health Care Services (621)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Home Health Care Services (8082)

akta.pro primary industry

Home Hospice Agencies (HLAFAEAC)

Keywords

• Dialysis services
• Nephrology care
• Home hemodialysis
• Peritoneal dialysis
• Kidney disease treatment

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices13 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Supply Chain, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Healthcare service billing (Sécurité sociale / Assurance Maladie): AURA Paris bills dialysis and nephrology healthcare services to the French public health insurance system (Sécurité sociale) and supplemental health insurers, following the French ESPIC (Établissement de Santé Privé d'Intérêt Collectif) billing framework. Prices published: Medicine daily rate €1,139.70, SMR daily rate €302, Day Hospital €905.16, specialized consultation €23.
2. Continuing professional education (FID): The FID training center generates revenue through fee-based professional training courses for healthcare workers in nephrology and dialysis, with per-participant pricing (e.g., €350, €700, €1,050, €1,750 per course).
3. Dialysis seasonal/travel services: AURA organizes dialysis for traveling patients, with feasibility studies conducted and partial cost recovery for material transport, particularly for international travel.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels6 records

Core offering

AURA Paris is a non-profit healthcare association (ESPIC) that delivers comprehensive kidney disease care across Île-de-France through a network of 14 dialysis centers, a 24-bed nephrology hospitalization service, home dialysis programs, and specialist consultations. It also operates an internal FID training center providing Qualiopi-certified continuing professional education courses in dialysis, nephrology, and therapeutic patient education.

Product overview

AURA Paris is a non-profit healthcare association (Association pour l'Utilisation du Rein Artificiel) operating as a comprehensive kidney disease care network in Île-de-France. The organization offers a unified platform of dialysis services spanning in-center hemodialysis at 14 locations across the region, home-based dialysis options (daily home hemodialysis and peritoneal dialysis) through dedicated centers like PADD, and full hospitalization services with 24 nephrology beds. Supporting services include specialized consultations, seasonal/travel dialysis, therapeutic patient education programs, clinical research activities, and professional healthcare training via their FID center. The portfolio includes all renal replacement therapy modalities from prevention through transplantation, positioning AURA as an integrated nephrology care provider.

Differentiator

Problem solved

Functional benefit

Products and services

• Dialysis Centers (in-center hemodialysis network) Network of 14 dialysis treatment centers across Île-de-France offering in-center hemodialysis, self-dialysis (autodialyse), and monitored dialysis (UDM). Locations include Paris Plaisance (60 stations), Saint-Ouen, Bichat, Pelleport, Châtillon, Pontoise, Meaux, Melun, Corbeil, Montreuil, and others. For adult patients with end-stage renal disease.
• Home Hemodialysis (Hémodialyse à Domicile) Home hemodialysis program providing daily home hemodialysis treatment for patients trained in AURA facilities, enabling greater autonomy and flexibility in treatment scheduling. Currently 140 patients managed in partnership with referring nephrologists with support from AURA logistics.
• Peritoneal Dialysis (Dialyse Péritonéale) Peritoneal dialysis service managed in partnership with referring structures, providing an alternative home-based dialysis option for suitable patients. Currently 300 patients.
• Nephrology Hospitalization Service 24-bed nephrology hospitalization unit at AURA Paris Plaisance comprising 12 conventional care beds, 12 medical rehabilitation beds, and a day hospital, providing comprehensive kidney disease treatment for inpatient nephrology, medical rehabilitation, and day-hospital diagnostic and therapeutic procedures.
• Nephrology and Diabetology Consultations Specialized nephrology and diabetology consultations offered at multiple centers including Paris Plaisance (Mon-Fri 9h-17h), Saint-Ouen (Mon/Wed/Fri), and PADD (Montrouge). For patients requiring specialist assessment and follow-up.
• Seasonal/Travel Dialysis (Dialyse Saisonnière) Travel dialysis service enabling existing AURA patients to receive treatment at vacation destinations in France or abroad, with logistics coordination for equipment delivery.
• Therapeutic Patient Education (ETP) Structured education program (Éducation Thérapeutique du Patient) helping chronic kidney disease patients acquire self-care skills through individual and group workshops covering kidney function, vascular access, dialysis, medications, and nutrition.
• Clinical Research Program Research activities covering mineral bone disorder, anemia, neurological effects, vascular access, and innovative therapies. Includes a Scientific Council established in 2016, participation in CKD-REIN, REIN, RDPLF, and DOPPS cohorts, 63 Pubmed publications since 2015, and 15 ongoing clinical studies.
• FID Training Center (Continuing Professional Education) Healthcare professional training center (Formation Interne Dialyse) at Ivry-sur-Seine offering 18+ specialized Qualiopi-certified courses in dialysis, nephrology, therapeutic patient education, wound care, hygiene, peritoneal dialysis, elderly care, palliative care, and related topics. Per-participant pricing ranges from €350 to €1,750 net per course.

Quantifiable outcome

• 2500 active patients served (quarter of Greater Paris dialysis population)
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Partnerships

15 partnerships are on record, tiered core, major, moderate, minor and emerging.

• Assistance Publique-Hôpitaux de Paris (AP-HP)coreStrategic or Co-development PartnerAURA was historically founded in 1967 under the impulsion of Professor Jean Hamburger to take in charge AP patients on dialysis, with support from the Sécurité Sociale and Assistance Publique. Strong institutional links remain, with partnership conventions being activated to develop collaboration. Patients are referred from AP-HP hospitals and AURA provides training and education for AP-HP staff.
• Hôpital Saint Joseph (Paris)coreStrategic or Co-development PartnerAURA Paris Plaisance is physically located within the Hôpital Saint Joseph premises. Strong clinical collaboration includes nephrology service interactions, day hospital access to medical-technical platforms, and joint research activities. The service d'hémodialyse at Plaisance works closely with Hôpital Saint Joseph's departments.
• Centre Hospitalier Sud Francilien (CHSF)majorStrategic or Co-development PartnerDiscussions ongoing for UDM and UAD units associated with consultations and potentially a Hôpital de Jour. Project ambitions include partnership conditions to be defined. Dr Caudwell represents CHSF in collaborative medical project discussions.
• Hôpitaux de Montreuil, Evry, Melun, MeauxmoderateStrategic or Co-development PartnerAURA has developed referral and training relationships with hospitals in Montreuil, Evry, Melun, and Meaux. These partnerships provide patient referrals to AURA and enable staff training and education activities in return.
• RENIF (Réseau de Néphrologie d'Île-de-France)coreStrategic or Co-development PartnerRENIF is the nephrology network of Île-de-France, an association funded by the Agence Régionale de Santé. It develops screening, coordinated care management, and professional training in nephrology. AURA participates as a partner in coordinated patient care pathways including consultations, dietary workshops, therapeutic education, and nursing assessments.
• Université Paris-Saclay, Versailles Saint-Quentin-en-YvelinesmoderateStrategic or Co-development PartnerAURA is a motor element in the creation of a Diplôme d'Université des Maladies Rénales under the supervision of Université Paris-Saclay, Versailles Saint-Quentin-en-Yvelines. This academic partnership supports medical education and teaching activities.
• AIRG-France (Association pour l'Information et la Recherche sur les Maladies Rénales Génétiques)minorGTM or Marketing PartnerPatient association providing information on genetic kidney diseases and offering support to patients and families. Listed as a useful link on AURA's website.
• France ReinmoderateGTM or Marketing PartnerIndependent patient association expert in kidney disease, working to prevent kidney disease progression, influence public health policy, and improve patient quality of life. Listed as a useful link on AURA's website.
• RenaloominorGTM or Marketing PartnerPatient association providing support, information, and mutual aid to people affected by chronic kidney disease, on dialysis or transplanted, and their families. Listed as a useful link on AURA's website.
• REIN ECHOSminorGTM or Marketing PartnerAssociation dedicated to kidney diseases, created by patients, with the aim of broad information on kidney failure and its treatments. Listed as a useful link on AURA's website.
• Académie de médecinecoreStrategic or Co-development PartnerProfesseur Ziad Massy (Director of Medical, Research and Teaching) and Professor Pierre Ronco (President) are both members of the Académie de médecine. A working group on kidney disease has been created within the Academy, contributing to national health policy influence.
• Hôpital Foch (DRCI)moderateStrategic or Co-development PartnerAURA participates in the steering committee of the chronic kidney disease research network of the FEHAP, with support from Hôpital Foch's DRCI (Département de la Recherche Clinique et de l'Innovation).
• FEHAP (Fédération des Etablissements Hospitaliers et d'Aide à la Personne)moderateStrategic or Co-development PartnerAURA participates in the FEHAP's chronic kidney disease research network. FEHAP provides a framework for research collaboration among healthcare establishments.
• Agence de la BiomédecinemoderateStrategic or Co-development PartnerAURA prepares patients for renal transplantation and assists with listing on the national waiting list managed by the Agence de la Biomédecine. Partnership with various AP-HP hospitals for transplantation preparation and post-transplant follow-up.
• International partners (Africa, Southeast Asia, Middle East, Saudi Arabia)emergingStrategic or Co-development PartnerAURA is developing international relations with collaborations in Africa, Southeast Asia, and the Middle East. A potential partnership with Saudi Arabia was recently mentioned, indicating emerging international expansion.

Scale indicators13 records

Recent moves10 records

Expansion highlights4 records

Direct peers

• Diaverum: One of the largest independent dialysis service networks globally with a meaningful French footprint, operating outpatient hemodialysis centers, home dialysis programs, and integrated nephrology care — directly comparable to AURA Paris across modalities and care model.
• Santé Service: Leading French home healthcare provider (HAD) delivering complex nursing care including home dialysis support; directly comparable to AURA's home hemodialysis and peritoneal dialysis programs in terms of clinical scope and home-based delivery model.
• NephroCare: Fresenius Medical Care's dedicated outpatient dialysis clinic brand; runs hundreds of dialysis centers across Europe offering hemodialysis and home dialysis services that directly overlap with AURA's center-based and home-based dialysis portfolio.

Others

• Doctolib: France's dominant healthcare booking and teleconsultation platform; integrated as AURA's online appointment scheduling channel across Plaisance, PADD, Saint-Ouen, and Châtillon — an enabling ecosystem partner rather than a direct competitor.

Broad incumbents

• Emeis (formerly Orpea): Major French/European operator of nursing care, residential care, and post-acute facilities including chronic disease programs; comparable to AURA's hospitalization service (SMR) and broader chronic care footprint, though dialysis is not its primary service line.
• Fresenius Medical Care: Global leader in dialysis products and services, operating thousands of dialysis clinics worldwide (including via NephroCare) and providing in-center and home dialysis comparable to AURA's offerings, though at vastly greater scale and with a product/manufacturing business.
• B. Braun Avitum: Dialysis services arm of B. Braun, one of Europe's largest renal care providers operating in-center and home dialysis clinics with vertically integrated products (machines, dialyzers) — comparable in service scope but with broader product breadth than AURA.
• Elsan: Major French private clinic operator with a network of inpatient and outpatient facilities; competes for hospital partnerships, nephrology talent, and ESPIC-style payer relationships across the same regional geography as AURA.
• Ramsay Santé: Largest private hospital group in France, providing multi-specialty inpatient and outpatient services; competes for the same physician referral and payer relationships in Île-de-France even though nephrology/dialysis is not its primary focus.

Regional players

• Assistance Publique - Hôpitaux de Paris (AP-HP): Largest public hospital system in Europe, anchoring nephrology and dialysis care in Île-de-France; AURA was originally founded to serve AP-HP dialysis patients and continues to operate closely with AP-HP hospitals as both a referral partner and a partial substitute.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AURA Paris